Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 6, 2019

Study Completion Date

February 6, 2019

Conditions
Cardiomyopathy
Interventions
DEVICE

Three-lead CRT-D (Defibrillator)

The three-lead CRT-D (Defibrillator) will consist of a pulse generator, a right atrial lead, a right ventricular lead and a left ventricular lead.

Trial Locations (9)

10032

New York Presbyterian Hospita/Columbia University Medical Center, New York

14642

Univeristy of Rochester Medical Center, Rochester

20010

MedStar Washington Hospital Center, Washington D.C.

33606

University of South Florida, Tampa

37232

Vanderbilt University Medical Center, Nashville

63110

Washington University, St Louis

77030

MD Anderson Cancer Center, Houston

90095

UCLA Cardiovascular Center, Los Angeles

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

University of Rochester

OTHER

NCT02164721 - Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy | Biotech Hunter | Biotech Hunter